Response assessment in advanced pancreatic cancer (APC) is difficult and predictive markers are needed. There are insufficient data on the value of carbohydrate antigen 19–9 (CA 19-9) and ...

Second interim analysis of the Global Investigation of Therapeutic Decisions in Unresectable HCC (uHCC) and of Its Treatment with Sorafenib (GIDEON): Differences in AE reporting across physician ...

To investigate the prognostic value of quality of life (QOL) relative to tumour marker carbohydrate antigen (CA) 19-9, and the role of CA 19-9 in estimating palliation in patients with advanced ...

Type 2 diabetes mellitus is a risk factor for pancreatic cancer which is increasing worldwide. A research group from Turkey has found that the use of a tumor marker, Ca 19-9, in diabetics with a ...

Oct. 3, 2003 -- Very high levels of CA19-9 may indicate unresectable pancreatic cancer despite the appearance on imaging, according to the results of a study published in the September issue of the ...

Cell-free junctional DNA fragment from hepatitis B virus integration in HCC for monitoring postresection recurrence and clonality. r= elevated CA 19-9 ≥ 38 U/ml. This is an ASCO Meeting Abstract from ...

The prognosis of pancreatic cancer is extremely poor and early diagnosis is difficult. At the time of diagnosis, local vascular involvement, nodal and distant metastases are frequently present.

Having high levels of the biomarker carbohydrate antigen 19-9 before surgery is associated with bladder cancer recurrence among patients who undergo radical cystectomy. In patients with bladder cancer ...

“[...] these inexpensive, widely available tests with rapid turnaround times and relatively short half-lives (CEA, CA-125, and CA19-9) are perfectly situated to ...

CA19-9, or sialyl-Lewis, is a sugar molecule that's present on many proteins and is often elevated in patients with pancreatitis and pancreatic cancer. Therefore it has been used for more than 30 ...